CRISPR Therapeutics to Participate in Three June Conferences – GlobeNewswire (press release)
Investorplace.com |
CRISPR Therapeutics to Participate in Three June Conferences
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., June 05, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that … Buy These 2 Biotech Stocks on the Dip After an FDA Delay — The … After Soaring to New Highs, Crispr Therapeutics AG Stock Ripe for a Fall Major human CRISPR trial derailed by FDA—at least for now |
